The HDA Research Foundation is seeking to support the next generation of supply chain leaders through a new scholarship program. Created in conjunction with HDA’s professional development program, Convene, the HDA Research Foundation Scholarship is available biannually to graduate-level students currently working within HDA-member distributor and manufacturer companies.
The Healthcare Distribution Alliance (HDA) announces today the election of Greg Drew, President of Value Drug Company, as Chairman of HDA’s Board of Directors. Robert Mauch, PhD, PharmD, EVP and Group President at AmerisourceBergen Corporation, was elected Vice Chairman. The new leadership was announced at the HDA Annual Board and Membership Meeting.
Allied Against Opioid Abuse (AAOA), a national initiative to help prevent prescription opioid abuse and misuse through education, has created a pharmacy toolkit (http://bit.ly/2xiNmnj) to equip pharmacists with resources to engage and educate patients about the safe use, storage and disposal of pain medicines.
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement on the Senate passage of comprehensive opioid legislation, the SUPPORT for Patients and Communities Act (H.R. 6).
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement on the introduction of the Using Data to Prevent Opioid Diversion Act of 2018 (H.R. 6779) by Rep. Ken Buck (R-Colo.)
John Parker
(703) 885-0216
Farah Simonett
(703) 885-0269
